Behbahani Ali is a director of Adaptimmune Therapeutics Plc.
Person profile
Roles
Address
Chevy Chase, Maryland
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
CRISPR Therapeutics AG
31 May 24
4
Korro Bio, Inc.
24 Apr 24
4
NeueHealth, Inc.
10 Apr 24
4
Black Diamond Therapeutics, Inc.
3 Apr 24
4
Adaptimmune Therapeutics PLC
17 Jan 24
4
Bright Health Group Inc.
21 Dec 23
4
CVRx, Inc.
18 Dec 23
4
Black Diamond Therapeutics, Inc.
15 Dec 23
4
Korro Bio, Inc.
7 Nov 23
3
Korro Bio, Inc.
7 Nov 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 May 24 | CRSP CRISPR Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 54.06 | 13,000 | 702.78 k | 13,000 |
22 Apr 24 | KRRO Korro Bio | Common Stock | Grant | Acquire A | Yes | No | 56 | 17,857 | 999.99 k | 1,090,793 |
8 Apr 24 | NEUE NeueHealth | Warrant Common Stock | Buy | Acquire P | Yes | No | 0.01 | 371,187 | 3.71 k | 371,187 |
8 Apr 24 | NEUE NeueHealth | Warrant Common Stock | Buy | Acquire P | Yes | No | 0.01 | 123,729 | 1.24 k | 123,729 |
8 Apr 24 | NEUE NeueHealth | Warrant Common Stock | Buy | Acquire P | Yes | No | 0.01 | 123,729 | 1.24 k | 123,729 |
15 Mar 24 | BDTX Black Diamond Therapeutics | Common Stock | Grant | Acquire A | No | No | 4.54 | 3,166 | 14.37 k | 51,690 |
15 Jan 24 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.14 | 40,950 | 5.73 k | 40,950 |